Effects of Cervical Manual Therapy for Temporomandibular Disorders With Myalgia
Background: Temporomandibular disorders (TMDs) are the leading cause of non-odontogenic orofacial pain interfering with daily activities. TMDs consist of a group of conditions affecting the masticatory muscles, the temporomandibular joint (TMJ), or the associated structures. Previous studies showed alterations in TMJ kinematics, cortical excitability, electromyographic (EMG) activity of the masticatory muscles, and tongue pressure in individuals with TMDs compared to healthy controls. Furthermore, several studies have demonstrated that manual therapy applied to the cervical joint could reduce pain and improve jaw function in individuals with TMDs. However, the effects of upper cervical mobilization on TMJ kinematics, cortical excitability, tongue pressure, and EMG of masticatory muscles during mouth opening in individuals with myogenous TMDs remain unknown.
Purpose: This study aims to investigate the immediate effects of upper cervical mobilization on TMJ kinematics, EMG of masticatory system muscles, cortical excitability, and tongue pressure in individuals with myogenous TMDs.
Methods: A randomized controlled trial will be conducted with a total sample size of 48 participants. Individuals diagnosed with myogenous TMDs, defined as chronic myalgia (lasting >3 months continuously or > 6 months intermittently) according to the Diagnostic Criteria for Temporomandibular Disorders, will be recruited for this study. Participants will be randomly assigned to either the experimental or the control group, stratified by age and sex. The experimental group will receive a single session of upper cervical mobilization, while the control group will receive a placebo maneuver. The primary outcomes will include TMJ kinematics and EMG activity of the masseter and suprahyoid muscles, while the secondary outcomes will include cortical excitability, tongue pressure, pain intensity, and upper cervical mobility. All measurements will be taken before and immediately after the intervention.
Statistical analysis: The continuous and categorical variables of clinical and demographic characteristics will be analyzed by an independent t test/Mann-Whitney U test and a Chi-square test, respectively. A 2×2 mixed-model analysis of variance (ANOVA) will be used to analyze the outcome measures and to test the main effects and interactions between time and group. If there is a significant interaction effect, post hoc pairwise comparisons with Bonferroni correction will be used. The alpha level is set at 0.05.
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Typ studie
Zápis (Odhadovaný)
Fáze
- Nelze použít
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dospělý
Přijímá zdravé dobrovolníky
Popis
Inclusion Criteria:
- Diagnosed with myogenous TMDs, defined as chronic myalgia (lasting >3 months continuously or > 6 months intermittently) 90 with or without accompanying arthralgia according to DC/TMD criteria
- A visual analogue scale (VAS) score of 3 or greater at baseline
- 18 to 60 years of age
Exclusion Criteria:
- Diagnosed with disc displacement without reduction or degenerative joint disease according to the DC/TMD criteria
- A diagnosis of systemic diseases such as fibromyalgia, rheumatoid arthritis, systemic erythematous lupus, or psoriatic arthritis
- A diagnosis of neurological disorders (e.g., trigeminal neuralgia, cervical radiculopathy, or myelopathy)
- Evidence of central nervous system involvement (positive pathological reflexes)
- A history of traumatic injuries (e.g., contusion, fracture, or whiplash injury) in the last 6 weeks
- Signs of vertebral artery insufficiency or upper cervical instability revealed by physical examination
- Receiving cervical spine mobilization or manipulation or acupuncture for their TMDs within the last 1 week
- any contraindication to TMS
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Dvojnásobek
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Komparátor placeba: Kontrolní skupina
|
Participants will also remain in a supine position with a neutral head posture.
However, instead of performing mobilization, the physical therapist will simply place their hands on C1 and C2 without applying any force.
|
|
Experimentální: Upper cervical mobilization
|
Upper cervical mobilization will focus on the atlanto-axial joint.
All techniques will adhere to the International Federation of Orthopaedic Manipulative Physical Therapists (IFOMPT) guidelines to minimize the risk of adverse effects 75.
Participants will remain in a supine position with their head in a neutral alignment.
The physical therapist will apply translatoric mobilization, aligning the transverse process of the atlas (C1) as closely as possible with the transverse process of the axis (C2) in the transverse plane.
The intervention will be considered complete once C1 and C2 are properly aligned.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Range of maximum mouth opening as assessed by Zebris Jaw Motion Analyzer device
Časové okno: Before and immediately after the intervention
|
Data will be presented in millimeters.
WinJaw software (Zebris Medical GmbH, Isny, Germany) will be used to collect and calculate the data.
|
Before and immediately after the intervention
|
|
Range of mandibular protrusion as assessed by Zebris Jaw Motion Analyzer device
Časové okno: Before and immediately after the intervention
|
Data will be presented in millimeters.
WinJaw software (Zebris Medical GmbH, Isny, Germany) will be used to collect and calculate the data.
|
Before and immediately after the intervention
|
|
Range of mandibular lateral excursion as assessed by Zebris Jaw Motion Analyzer device
Časové okno: Before and immediately after the intervention
|
Data will be presented in millimeters.
WinJaw software (Zebris Medical GmbH, Isny, Germany) will be used to collect and calculate the data.
|
Before and immediately after the intervention
|
|
Condylar path length as assessed by Zebris Jaw Motion Analyzer device
Časové okno: Before and immediately after the intervention
|
Data will be presented in millimeters.
Data will be collected during mouth opening and closing.
WinJaw software (Zebris Medical GmbH, Isny, Germany) will be used to collect and calculate the data.
|
Before and immediately after the intervention
|
|
Condylar rotation as assessed by Zebris Jaw Motion Analyzer device
Časové okno: Before and immediately after the intervention
|
Data will be presented in degrees.
Data will be collected during mouth opening and closing.
WinJaw software (Zebris Medical GmbH, Isny, Germany) will be used to collect and calculate the data.
|
Before and immediately after the intervention
|
|
Condylar translation as assessed by Zebris Jaw Motion Analyzer device
Časové okno: Before and immediately after the intervention
|
Data will be presented in millimeters.
Data will be collected during mouth opening and closing.
WinJaw software (Zebris Medical GmbH, Isny, Germany) will be used to collect and calculate the data.
|
Before and immediately after the intervention
|
|
Activation of masseter muscles as assessed by surface electromyography (sEMG) (BIOPAC MP150 system)
Časové okno: Before and immediately after the intervention
|
sEMG recordings will be acquired during both TMJ kinematic assessments and maximum voluntary clenching (MVC) tasks. To standardize the results, sEMG amplitudes from the kinematic tests will be presented as normalized values (%MVC), calculated as the ratio of task-specific sEMG activity to the maximal activity recorded during MVC. |
Before and immediately after the intervention
|
|
Activation of suprahyoid muscles as assessed by surface electromyography (sEMG) (BIOPAC MP150 system)
Časové okno: Before and immediately after the intervention
|
sEMG recordings will be acquired during both TMJ kinematic assessments and maximum voluntary clenching (MVC) tasks. To standardize the results, sEMG amplitudes from the kinematic tests will be presented as normalized values (%MVC), calculated as the ratio of task-specific sEMG activity to the maximal activity recorded during MVC. |
Before and immediately after the intervention
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Cortical excitability of M1 as assessed by Magstim transcranial magnetic stimulator
Časové okno: Before and immediately after the intervention
|
Resting motor threshold, motor evoked potentials, short-interval intracortical inhibition, and intracortical facilitation of masseter muscle will be collected. LabChart 8 will be used for data collection and statistical analysis. |
Before and immediately after the intervention
|
|
Maximum tongue pressure values as assessed by wireless tongue pressure measurement device (OCPT-168, Shi-Heng Technology Co. Ltd., Taiwan)
Časové okno: Before and immediately after the intervention
|
Data will be presented as kPa.
The subject was asked to perform the maximum tongue protrusion force that could be exerted.
|
Before and immediately after the intervention
|
|
Self reported masticatory muscle pain intensity as assessed by Visual Analog Scale
Časové okno: Before and immediately after the intervention
|
Zero is equivalent to no pain, and 10 indicates the worst possible pain.
|
Before and immediately after the intervention
|
|
Upper cervical mobility as assessed by flexion-rotation test at atlanto-axial level
Časové okno: Before and immediately after the intervention
|
A cervical range of motion device will be used to measure rotation.
|
Before and immediately after the intervention
|
Spolupracovníci a vyšetřovatelé
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Odhadovaný)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
Další identifikační čísla studie
- NYCU114159AF
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na upper cervical mobilization
-
International Food Policy Research InstituteDepartment for International Development, United Kingdom; Institute of Development... a další spolupracovníciDokončenoVýživový stav dítěte | Diverzita stravy v domácnosti | Mateřské nutriční znalosti a praxeBangladéš
-
Mardin Artuklu UniversityZápis na pozvánkuSyndromy obstrukční spánkové apnoeTurecko (Türkiye)
-
Galena Innovations, LLCZatím nenabírámePředčasný porod | Cervikální nedostatečnost | Krátký děložní čípek | Cervikální neschopnost | Měkký děložní čípekSpojené státy
-
Restor3DUkončenoDegenerativní onemocnění ploténekSpojené státy
-
Riphah International UniversityZatím nenabírámePlantární fasciitida | Syndrom bolesti patyPákistán
-
Lahore University of Biological and Applied SciencesDokončeno
-
Orthofix Inc.UkončenoOdontoidní zlomenina typu II
-
Cairo UniversityDokončenoLumbosakrální radikulopatie | Lumbální radikulopatie v důsledku komprese míšního nervu | Bederní Disk Prolaps S Radikulopatií | LUMBÁLNÍ RADIKULOPATIEEgypt
-
Synergy Spine SolutionsMCRANábor